Ketamine vs SSRIs: Pharmacological Comparison for Healthcare Professionals

# Ketamine vs SSRIs: Clinical Pharmacological Analysis ## Mechanism of Action Comparison ### SSRI Mechanism - Selective serotonin reuptake inhibition - Monoamine hypothesis of depression - 6-8 week onset of therapeutic effect - 60-70% response rate in treatment-naive patients ### Ketamine Mechanism - NMDA receptor antagonism - Glutamate system modulation - Rapid neuroplasticity promotion - Hours to days onset of effect ## Clinical Efficacy Data ### Treatment-Resistant Depression - SSRIs: 30% response rate after multiple failures - Ketamine: 70% response rate in treatment-resistant cases - Ketamine shows superior efficacy in refractory depression ### Speed of Onset - SSRIs: 4-8 weeks for full therapeutic effect - Ketamine: 24-72 hours for initial response - Critical advantage in suicidal ideation cases ## Prescribing Considerations ### SSRI Prescribing - First-line treatment for depression - Well-established safety profile - Insurance coverage typically available - Extensive drug interaction database ### Ketamine Prescribing - Reserved for treatment-resistant cases - Requires specialized supervision - Limited insurance coverage - Newer safety database ## Side Effect Profiles ### Common SSRI Effects - Sexual dysfunction (60-70%) - Weight gain - Gastrointestinal effects - Sleep disturbances ### Ketamine Effects - Transient dissociation - Nausea (30-40%) - Dizziness - Hypertension (transient) ## Professional Practice Integration ### When to Consider Ketamine - Failed 2+ adequate SSRI trials - Acute suicidal ideation - Severe treatment-resistant depression - Patient preference after informed consent ## Conclusion Ketamine represents a paradigm shift in depression treatment, particularly for treatment-resistant cases where SSRIs have proven inadequate. *DiscreetKetamine offers professional consultation for ketamine therapy implementation.*